%PDF-1.6
%âãÏÓ
1 0 obj
<>
endobj
2 0 obj
<>stream
Mar Siles-Lucas, Adriano Casulli, Roberto Cirilli, David Carmena
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets
www.plosntds.org
www.plosntds.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref001)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref002)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/A 19 0 R>>
endobj
19 0 obj
<>
endobj
14 0 obj
[20 0 R 21 0 R 22 0 R 23 0 R 24 0 R]
endobj
20 0 obj
<>stream
q
0.955 g
0 w
199.9998 713.9999 m
575.9997 713.9999 l
575.9997 475.0004 l
199.9998 475.0004 l
f*
0.83 0.64 0.02 0 k
484.4409 289.9276 m
489.2031 289.9276 l
h
f*
491.4709 289.9276 m
496.2331 289.9276 l
h
f*
509.3858 146.948 m
514.148 146.948 l
h
f*
0 g
1 j
1 J
11.9999 0 0 11.9999 209.9905 696.0188 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Author)Tj
3.137 0 Td
(summary)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 209.9905 677.9905 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Human)Tj
3.3165 0 Td
(cystic)Tj
2.4491 0 Td
(and)Tj
1.7291 0 Td
(alveolar)Tj
3.3392 0 Td
(echinococcosis)Tj
6.1908 0 Td
(\(CE)Tj
1.7915 0 Td
(and)Tj
1.7291 0 Td
(AE\),)Tj
2.041 0 Td
(caused)Tj
2.9196 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4684 0 Td
(larval)Tj
2.4094 0 Td
(stages)Tj
2.5625 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-34.1402 -1.2982 Td
(helminths)Tj
/F11 1 Tf
4.2406 0 Td
[()-1()13()18()12()6()4()7()4()7()1()-4()]TJ
5.3461 0 Td
[( )-8(\n)20()16()18()4()4()7()10()-4()]TJ
/F7 1 Tf
4.422 0 Td
(and)Tj
/F11 1 Tf
1.7291 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
(,)Tj
5.8337 0 Td
(respectively,)Tj
5.1137 0 Td
(are)Tj
1.4456 0 Td
(progressive)Tj
4.7452 0 Td
(and)Tj
-33.8681 -1.2983 Td
(chronic)Tj
3.2881 0 Td
(diseases)Tj
3.3789 0 Td
(affecting)Tj
3.6567 0 Td
(more)Tj
2.3414 0 Td
(than)Tj
2.0296 0 Td
(1)Tj
0.6973 0 Td
(million)Tj
3.1181 0 Td
(people)Tj
2.8573 0 Td
(worldwide.)Tj
4.6828 0 Td
(Both)Tj
2.1316 0 Td
(are)Tj
1.4513 0 Td
(considered)Tj
-29.6331 -1.3039 Td
(orphan)Tj
3.1294 0 Td
(and)Tj
1.7291 0 Td
(neglected)Tj
3.9968 0 Td
(diseases)Tj
3.3789 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(World)Tj
2.8403 0 Td
(Health)Tj
2.914 0 Td
(Organization.)Tj
5.7486 0 Td
(As)Tj
1.2643 0 Td
(a)Tj
0.6519 0 Td
(treatment)Tj
-28.3065 -1.2983 Td
(approach,)Tj
4.1782 0 Td
(chemotherapy)Tj
5.947 0 Td
(is)Tj
0.8504 0 Td
(limited)Tj
3.0671 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(use)Tj
1.5363 0 Td
(of)Tj
1.0148 0 Td
(benzimidazoles,)Tj
6.599 0 Td
(drugs)Tj
2.4775 0 Td
(that)Tj
1.7745 0 Td
(stop)Tj
1.9049 0 Td
(parasite)Tj
-31.8442 -1.2982 Td
(growth)Tj
3.0727 0 Td
(but)Tj
1.5534 0 Td
(do)Tj
1.2585 0 Td
(not)Tj
1.5704 0 Td
(kill)Tj
1.4797 0 Td
(the)Tj
1.4683 0 Td
(parasite.)Tj
3.549 0 Td
(To)Tj
1.3379 0 Td
(compensate)Tj
4.9776 0 Td
(this)Tj
1.6725 0 Td
(therapeutic)Tj
4.7338 0 Td
(shortfall,)Tj
3.7247 0 Td
(new)Tj
1.8765 0 Td
(treat-)Tj
-32.275 -1.3039 Td
(ment)Tj
2.313 0 Td
(alternatives)Tj
4.7792 0 Td
(are)Tj
1.4456 0 Td
(urgently)Tj
3.5603 0 Td
(needed.)Tj
3.3166 0 Td
(Here,)Tj
2.4321 0 Td
(we)Tj
1.3266 0 Td
(present)Tj
3.1634 0 Td
(the)Tj
1.474 0 Td
(state-of-the-art)Tj
6.2305 0 Td
(regarding)Tj
4.0932 0 Td
(the)Tj
-34.1345 -1.2983 Td
(alternative)Tj
4.422 0 Td
(compounds)Tj
4.9606 0 Td
(and)Tj
1.7291 0 Td
(new)Tj
1.8765 0 Td
(formulations)Tj
5.3915 0 Td
(of)Tj
1.0148 0 Td
(benzimidazoles)Tj
6.3779 0 Td
(assayed)Tj
3.2201 0 Td
(against)Tj
3.0274 0 Td
(these)Tj
2.2507 0 Td
(dis-)Tj
-34.2706 -1.2983 Td
(eases)Tj
2.2223 0 Td
(until)Tj
2.109 0 Td
(now.)Tj
2.1826 0 Td
(Some)Tj
2.4491 0 Td
(of)Tj
1.0148 0 Td
(these)Tj
2.2507 0 Td
(new)Tj
1.8766 0 Td
(and)Tj
1.7348 0 Td
(modified)Tj
3.8437 0 Td
(compounds,)Tj
5.1874 0 Td
(either)Tj
2.5285 0 Td
(alone)Tj
2.381 0 Td
(or)Tj
1.0999 0 Td
(in)Tj
1.0318 0 Td
(combina-)Tj
-31.9122 -1.3039 Td
(tion,)Tj
2.0692 0 Td
(could)Tj
2.4491 0 Td
(represent)Tj
3.9572 0 Td
(a)Tj
0.6576 0 Td
(step)Tj
1.8199 0 Td
(forward)Tj
3.4015 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(CE)Tj
1.4513 0 Td
(and)Tj
1.7291 0 Td
(AE.)Tj
1.7008 0 Td
(Unfortunately,)Tj
6.1285 0 Td
(few)Tj
-33.0234 -1.2983 Td
(compounds)Tj
4.9605 0 Td
(have)Tj
2.058 0 Td
(reached)Tj
3.3505 0 Td
(clinical)Tj
3.0784 0 Td
(trials)Tj
2.1997 0 Td
(stage)Tj
2.1997 0 Td
(in)Tj
1.0374 0 Td
(humans)Tj
3.4356 0 Td
(and,)Tj
1.9559 0 Td
(when)Tj
2.4038 0 Td
(assayed,)Tj
3.4412 0 Td
(the)Tj
1.474 0 Td
(design)Tj
2.812 0 Td
(of)Tj
-34.4067 -1.2982 Td
(these)Tj
2.2563 0 Td
(studies)Tj
2.9877 0 Td
(has)Tj
1.542 0 Td
(not)Tj
1.5704 0 Td
(allowed)Tj
3.2882 0 Td
(evidence-based)Tj
6.3156 0 Td
(conclusions.)Tj
5.1703 0 Td
(Thus,)Tj
2.4718 0 Td
(there)Tj
2.262 0 Td
(is)Tj
0.8504 0 Td
(still)Tj
1.6384 0 Td
(an)Tj
1.2019 0 Td
(urgent)Tj
-31.555 -1.2983 Td
(need)Tj
2.1429 0 Td
(for)Tj
1.389 0 Td
(defining)Tj
3.5546 0 Td
(new)Tj
1.8765 0 Td
(compounds)Tj
4.9606 0 Td
(or)Tj
1.0942 0 Td
(improved)Tj
4.1102 0 Td
(formulations)Tj
5.3971 0 Td
(of)Tj
1.0148 0 Td
(those)Tj
2.3358 0 Td
(already)Tj
3.1124 0 Td
(assayed,)Tj
-30.9881 -1.3039 Td
(and)Tj
1.7291 0 Td
(also)Tj
1.7688 0 Td
(for)Tj
1.3889 0 Td
(a)Tj
0.652 0 Td
(careful)Tj
2.9367 0 Td
(design)Tj
2.8119 0 Td
(of)Tj
1.0148 0 Td
(clinical)Tj
3.0728 0 Td
(protocols)Tj
3.9628 0 Td
(that)Tj
1.7745 0 Td
(could)Tj
2.4547 0 Td
(lead)Tj
1.8482 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.474 0 Td
(draw)Tj
2.2337 0 Td
(of)Tj
1.0147 0 Td
(a)Tj
0.6577 0 Td
(broad)Tj
-31.8215 -1.2983 Td
(international)Tj
5.4141 0 Td
(consensus)Tj
4.2803 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(use)Tj
1.5364 0 Td
(of)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(defined)Tj
3.2258 0 Td
(drug,)Tj
2.3358 0 Td
(or)Tj
1.0998 0 Td
(a)Tj
0.652 0 Td
(combination)Tj
5.3517 0 Td
(of)Tj
1.0148 0 Td
(drugs,)Tj
2.6986 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
-33.4032 -1.2982 Td
(effective)Tj
3.5092 0 Td
(treatment)Tj
4.1386 0 Td
(of)Tj
1.0148 0 Td
(CE)Tj
1.4513 0 Td
(and)Tj
1.7291 0 Td
(AE.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 425.0267 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 408.0188 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Human)Tj
3.3165 0 Td
(cystic)Tj
2.4491 0 Td
(and)Tj
1.7291 0 Td
(alveolar)Tj
3.3392 0 Td
(echinococcosis)Tj
6.1908 0 Td
(\(CE)Tj
1.7915 0 Td
(and)Tj
1.7291 0 Td
(AE\))Tj
1.8142 0 Td
(are)Tj
1.4457 0 Td
(chronic)Tj
3.2938 0 Td
(diseases)Tj
3.3732 0 Td
(caused)Tj
2.9197 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(lar-)Tj
-36.0451 -1.3039 Td
(val)Tj
1.3549 0 Td
(stages)Tj
2.5625 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(cestodes)Tj
/F11 1 Tf
3.5433 0 Td
[()-1()13()18()12()6()4()7()4()7()1()-4()]TJ
5.3461 0 Td
[( )-8(\n)20()16()18()4()4()7()10()-4()]TJ
/F7 1 Tf
4.4221 0 Td
(sensu)Tj
2.4434 0 Td
(lato)Tj
1.7064 0 Td
(\(s.l.\))Tj
1.9559 0 Td
(and)Tj
/F11 1 Tf
1.7292 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9978 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
(,)Tj
5.8279 0 Td
(respec-)Tj
-34.3726 -1.2982 Td
(tively.)Tj
2.5908 0 Td
(Both)Tj
2.1316 0 Td
(parasites)Tj
3.6851 0 Td
(can)Tj
1.627 0 Td
(develop)Tj
3.3222 0 Td
(in)Tj
1.0318 0 Td
(humans)Tj
3.4413 0 Td
(after)Tj
2.0352 0 Td
(ingestion)Tj
3.9061 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(infective)Tj
3.617 0 Td
(eggs)Tj
1.9332 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(parasite)Tj
-34.2876 -1.2983 Td
(shed)Tj
2.0579 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(faeces)Tj
2.5738 0 Td
(of)Tj
1.0148 0 Td
(canid)Tj
2.4208 0 Td
(definitive)Tj
3.9855 0 Td
(hosts.)Tj
2.5001 0 Td
(The)Tj
1.7802 0 Td
(oncospheres)Tj
5.193 0 Td
(released)Tj
3.4299 0 Td
(from)Tj
2.2054 0 Td
(the)Tj
1.474 0 Td
(eggs)Tj
1.9332 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
-34.1119 -1.3039 Td
(intestine)Tj
3.6566 0 Td
(penetrate)Tj
3.9572 0 Td
(the)Tj
1.4683 0 Td
(gut)Tj
1.5137 0 Td
(wall)Tj
1.8312 0 Td
(and)Tj
1.7291 0 Td
(enter)Tj
2.2847 0 Td
(the)Tj
1.4683 0 Td
(blood)Tj
2.5172 0 Td
(vessels,)Tj
3.0727 0 Td
(reaching)Tj
3.685 0 Td
(different)Tj
3.651 0 Td
(organs,)Tj
3.1351 0 Td
(mainly)Tj
-33.9701 -1.2983 Td
(liver)Tj
1.9729 0 Td
(and)Tj
1.7177 0 Td
(lungs,)Tj
2.5852 0 Td
(in)Tj
1.0262 0 Td
(which)Tj
2.6418 0 Td
(they)Tj
1.9162 0 Td
(develop)Tj
3.3109 0 Td
(into)Tj
1.8311 0 Td
(the)Tj
1.457 0 Td
(asexual)Tj
3.1011 0 Td
(cystic)Tj
2.4378 0 Td
(stage.)Tj
2.4208 0 Td
(In)Tj
1.0998 0 Td
(AE)Tj
1.4627 0 Td
(proliferative)Tj
5.0796 0 Td
(metaces-)Tj
-34.0608 -1.2982 Td
(tode)Tj
1.9729 0 Td
(vesicles)Tj
3.1804 0 Td
(intermingle)Tj
4.9039 0 Td
(with)Tj
1.9956 0 Td
(host)Tj
1.9105 0 Td
(connective)Tj
4.5411 0 Td
(tissue)Tj
2.4605 0 Td
(and)Tj
1.7291 0 Td
(immune)Tj
3.6283 0 Td
(cells)Tj
1.9162 0 Td
(and)Tj
1.7291 0 Td
(grow)Tj
2.2507 0 Td
(steadily)Tj
3.2315 0 Td
(and)Tj
-35.4498 -1.2983 Td
(in)Tj
1.0318 0 Td
(an)Tj
1.2075 0 Td
(infiltrative)Tj
4.3823 0 Td
(manner)Tj
3.3676 0 Td
(resembling)Tj
4.6488 0 Td
(that)Tj
1.7801 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.846 0 Td
(progression,)Tj
5.142 0 Td
(while)Tj
2.3697 0 Td
(CE)Tj
1.4514 0 Td
(single)Tj
2.5341 0 Td
(or)Tj
1.0999 0 Td
(multiple)Tj
-32.876 -1.3039 Td
(cyst)Tj
1.7574 0 Td
(growth)Tj
3.0728 0 Td
(is)Tj
0.8503 0 Td
(slow)Tj
2.0183 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(living)Tj
2.4661 0 Td
(parasite)Tj
3.3278 0 Td
(tissue)Tj
2.4605 0 Td
(remains)Tj
3.4469 0 Td
(enclosed)Tj
3.6793 0 Td
(by)Tj
1.1793 0 Td
(the)Tj
1.4683 0 Td
(external)Tj
3.4356 0 Td
(laminated)Tj
-32.3601 -1.2983 Td
(and)Tj
1.7291 0 Td
(adventitial)Tj
4.422 0 Td
(layers,)Tj
2.7326 0 Td
(resulting)Tj
3.7303 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(fluid-filled)Tj
4.4277 0 Td
(spherical)Tj
3.787 0 Td
(shaped)Tj
3.0161 0 Td
(lesion)Tj
2.5738 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
-26.9119 -1.2983 Td
(Treatment)Tj
4.4503 0 Td
(options)Tj
3.2258 0 Td
(for)Tj
1.389 0 Td
(AE)Tj
1.474 0 Td
(are)Tj
1.4457 0 Td
(few,)Tj
1.8425 0 Td
(with)Tj
1.9956 0 Td
(surgery)Tj
3.1974 0 Td
(reserved)Tj
3.5773 0 Td
(for)Tj
1.3833 0 Td
(early)Tj
2.1487 0 Td
(stages)Tj
2.5625 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(infection)Tj
-32.3771 -1.3039 Td
(when)Tj
2.4037 0 Td
(lesions)Tj
2.931 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1509 0 Td
(completely)Tj
4.5807 0 Td
(resected)Tj
3.4696 0 Td
(and)Tj
1.7348 0 Td
(there)Tj
2.262 0 Td
(are)Tj
1.4514 0 Td
(not)Tj
1.5703 0 Td
(distant)Tj
2.9594 0 Td
(metastases,)Tj
4.6544 0 Td
(followed)Tj
3.651 0 Td
(by)Tj
1.1849 0 Td
(pro-)Tj
-35.6312 -1.2982 Td
(phylactic)Tj
3.8097 0 Td
(anti-parasite)Tj
5.227 0 Td
(drug)Tj
2.109 0 Td
(treatment.)Tj
4.3653 0 Td
(Savage)Tj
2.9027 0 Td
(treatment)Tj
4.1385 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1509 0 Td
(attempted)Tj
4.2632 0 Td
(in)Tj
1.0318 0 Td
(advanced)Tj
3.9969 0 Td
(cases)Tj
-34.9226 -1.2983 Td
(by)Tj
1.1792 0 Td
(major)Tj
2.6078 0 Td
(palliative)Tj
3.8098 0 Td
(surgery)Tj
3.1974 0 Td
(or)Tj
1.0942 0 Td
(even)Tj
2.0749 0 Td
(liver)Tj
1.9786 0 Td
(transplantation,)Tj
6.5593 0 Td
(whereas)Tj
3.4469 0 Td
(in)Tj
1.0318 0 Td
(inoperable)Tj
4.4674 0 Td
(cases)Tj
2.2224 0 Td
(treatment)Tj
-33.6697 -1.3039 Td
(relies)Tj
2.313 0 Td
(on)Tj
1.2756 0 Td
(prolonged)Tj
4.3313 0 Td
(administration)Tj
6.1682 0 Td
(of)Tj
1.0147 0 Td
(benzimidazole)Tj
6.0208 0 Td
(drugs.)Tj
2.6986 0 Td
(For)Tj
1.627 0 Td
(CE)Tj
1.4514 0 Td
(four)Tj
1.9105 0 Td
(treatment)Tj
4.1386 0 Td
(options)Tj
-32.9497 -1.2983 Td
(have)Tj
2.0579 0 Td
(been)Tj
2.126 0 Td
(suggested)Tj
4.0705 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(WHO)Tj
2.7042 0 Td
(classification)Tj
5.3461 0 Td
(of)Tj
1.0148 0 Td
(cyst)Tj
1.7575 0 Td
(stages)Tj
2.5625 0 Td
(as)Tj
1.0148 0 Td
(seen)Tj
1.9729 0 Td
(in)Tj
1.0375 0 Td
(imaging-based)Tj
-30.8804 -1.2982 Td
(techniques:)Tj
4.7508 0 Td
(percutaneous)Tj
5.5842 0 Td
(interventions)Tj
5.5389 0 Td
([Percutaneous-Aspiration-)Tj
10.7035 0 Td
(Injection)Tj
3.8324 0 Td
(and)Tj
1.7292 0 Td
(Re-Aspira-)Tj
-32.139 -1.304 Td
(tion)Tj
1.8425 0 Td
(\(PAIR\))Tj
3.101 0 Td
(and)Tj
1.7292 0 Td
(its)Tj
1.1508 0 Td
(modifications,)Tj
5.9584 0 Td
(percutaneous)Tj
5.5842 0 Td
(evacuation)Tj
4.5354 0 Td
(\(PEVAC\),)Tj
4.2973 0 Td
(Modified)Tj
3.9232 0 Td
(Catheteriza-)Tj
-32.122 -1.2982 Td
(tion)Tj
1.8425 0 Td
(Technique)Tj
4.4787 0 Td
(\(MoCaT\),)Tj
4.2292 0 Td
(and)Tj
1.7348 0 Td
(Dilatable)Tj
3.8098 0 Td
(Multi-Function)Tj
6.4516 0 Td
(Trocar)Tj
2.9367 0 Td
(\(DMFT\)],)Tj
4.2349 0 Td
(surgery,)Tj
-29.7182 -1.2983 Td
(chemotherapy,)Tj
6.1738 0 Td
(and)Tj
1.7291 0 Td
(a)Tj
0.652 0 Td
(watch-and-wait)Tj
6.4856 0 Td
(approach.)Tj
4.1782 0 Td
(For)Tj
1.6214 0 Td
(the)Tj
1.474 0 Td
(first)Tj
1.8029 0 Td
(two)Tj
1.7121 0 Td
(options,)Tj
3.4469 0 Td
(pre-)Tj
1.8878 0 Td
(and)Tj
1.7292 0 Td
(post-treat-)Tj
-32.893 -1.2983 Td
(ment)Tj
2.3073 0 Td
(and)Tj
1.7292 0 Td
(peri-interventional)Tj
7.7895 0 Td
(treatment)Tj
4.1329 0 Td
(with)Tj
2.0013 0 Td
(anti-parasitic)Tj
5.4878 0 Td
(drugs)Tj
2.4775 0 Td
(is)Tj
0.8447 0 Td
(also)Tj
1.7688 0 Td
(used)Tj
2.0579 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-29.4007 -1.3039 Td
(As)Tj
1.2699 0 Td
(a)Tj
0.6519 0 Td
(rule)Tj
1.7859 0 Td
(of)Tj
1.0148 0 Td
(thumb,)Tj
3.1294 0 Td
(the)Tj
1.4683 0 Td
(ideal)Tj
2.1203 0 Td
(agent)Tj
2.3868 0 Td
(for)Tj
1.3889 0 Td
(the)Tj
1.4684 0 Td
(chemotherapeutic)Tj
7.4324 0 Td
(treatment)Tj
4.1385 0 Td
(of)Tj
1.0148 0 Td
(CE)Tj
1.4514 0 Td
(and)Tj
1.7291 0 Td
(AE)Tj
-33.647 -1.2982 Td
(should)Tj
2.9139 0 Td
(comply)Tj
3.1918 0 Td
(with)Tj
1.9956 0 Td
(as)Tj
1.0148 0 Td
(many)Tj
2.4775 0 Td
(as)Tj
1.0148 0 Td
(possible)Tj
3.4072 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(following)Tj
3.9798 0 Td
(features:)Tj
3.5716 0 Td
(it)Tj
0.7824 0 Td
(should)Tj
2.9197 0 Td
(be)Tj
1.1508 0 Td
(selectively)Tj
4.2406 0 Td
(toxic)Tj
-35.1493 -1.2983 Td
(against)Tj
3.0273 0 Td
(the)Tj
1.4684 0 Td
(parasite)Tj
3.3278 0 Td
(\(but)Tj
1.8936 0 Td
(not)Tj
1.5703 0 Td
(the)Tj
1.474 0 Td
(host\),)Tj
2.4775 0 Td
(and)Tj
1.7291 0 Td
(endowed)Tj
3.8608 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(favorable)Tj
3.8834 0 Td
(pharmacokinetics)Tj
-27.3654 -1.3039 Td
(enabling)Tj
3.6566 0 Td
(good)Tj
2.228 0 Td
(solubility,)Tj
4.1273 0 Td
(absorption,)Tj
4.7621 0 Td
(and)Tj
1.7348 0 Td
(stability)Tj
3.3506 0 Td
(to)Tj
1.0261 0 Td
(reach)Tj
2.3981 0 Td
(the)Tj
1.474 0 Td
(target)Tj
2.5115 0 Td
(site)Tj
1.5647 0 Td
(at)Tj
0.9524 0 Td
(a)Tj
0.6577 0 Td
(concentration)Tj
-30.4439 -1.2983 Td
(sufficient)Tj
3.9117 0 Td
(to)Tj
1.0262 0 Td
(trigger)Tj
2.88 0 Td
(an)Tj
1.2018 0 Td
(effective)Tj
3.5093 0 Td
(response)Tj
3.736 0 Td
(at)Tj
0.9525 0 Td
(the)Tj
1.4683 0 Td
(tissue)Tj
2.4605 0 Td
(and)Tj
1.7291 0 Td
(intra-cystic)Tj
4.7168 0 Td
(levels.)Tj
2.6022 0 Td
(A)Tj
0.9014 0 Td
(parasitocidal,)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 355.9748 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Progress)Tj
4.1598 0 Td
(in)Tj
0.978 0 Td
(the)Tj
1.5874 0 Td
(pharma)Tj
3.3307 0 Td
(cological)Tj
4.0253 0 Td
(treatment)Tj
4.3866 0 Td
(of)Tj
1.0347 0 Td
(human)Tj
3.2315 0 Td
(CE)Tj
1.5874 0 Td
(and)Tj
1.8567 0 Td
(AE)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00064)Tj
3.8197 0 Td
(22)Tj
0 g
2.0905 0 Td
(April)Tj
2.1827 0 Td
(20,)Tj
1.5804 0 Td
(2018)Tj
25.1647 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(48)Tj
/F8 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F9 1 Tf
0.4819 0 Td
(The)Tj
1.5875 0 Td
(authors)Tj
3.0401 0 Td
(have)Tj
1.963 0 Td
(declared)Tj
-14.7827 -1.3748 Td
(that)Tj
1.6228 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
21 0 obj
<>stream
endstream
endobj
22 0 obj
<>stream
endstream
endobj
23 0 obj
<>stream
endstream
endobj
24 0 obj
<>stream
BT
10.3394 82.7156 Td
(exist.)Tj
ET
Q
endstream
endobj
25 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 27 0 R/Contents 28 0 R/TrimBox[0 0 612 792]>>
endobj
27 0 obj
[29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R]
endobj
29 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref004)>>
endobj
30 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref005)>>
endobj
31 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref003)>>
endobj
32 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref005)>>
endobj
33 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref006)>>
endobj
34 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref007)>>
endobj
35 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref008)>>
endobj
36 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref008)>>
endobj
37 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref009)>>
endobj
38 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref010)>>
endobj
39 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref011)>>
endobj
40 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref012)>>
endobj
41 0 obj
<>/Border[0 0 0]/A 42 0 R>>
endobj
42 0 obj
<>
endobj
28 0 obj
[43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R]
endobj
43 0 obj
<>stream
q
0.83 0.64 0.02 0 k
383.4142 628.3276 m
388.1764 628.3276 l
h
f*
379.1622 576.3402 m
383.9244 576.3402 l
h
f*
439.7669 537.3354 m
444.5291 537.3354 l
h
f*
278.1921 498.3307 m
282.8976 498.3307 l
h
f*
285.1654 498.3307 m
289.9276 498.3307 l
h
f*
532.8 459.326 m
537.5622 459.326 l
h
f*
399.5717 381.3165 m
404.3339 381.3165 l
h
f*
483.4205 355.3512 m
488.1827 355.3512 l
h
f*
490.3937 355.3512 m
495.1559 355.3512 l
h
f*
463.4646 133.9087 m
472.989 133.9087 l
h
f*
490.9039 94.9039 m
500.4283 94.9039 l
h
f*
502.6394 94.9039 m
512.1638 94.9039 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(rather)Tj
2.6475 0 Td
(than)Tj
2.0239 0 Td
(a)Tj
0.6577 0 Td
(parasitostatic)Tj
5.4878 0 Td
(effect)Tj
2.3697 0 Td
(is)Tj
0.8448 0 Td
(also)Tj
1.7688 0 Td
(highly)Tj
2.7099 0 Td
(desirable,)Tj
4.0081 0 Td
(together)Tj
3.532 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(lack)Tj
1.8198 0 Td
(of)Tj
1.0148 0 Td
(undesirable)Tj
-31.538 -1.3039 Td
(clinical)Tj
3.0727 0 Td
(effects.)Tj
-1.8765 -1.2982 Td
(Currently)Tj
4.1272 0 Td
(available)Tj
3.668 0 Td
(drugs)Tj
2.4718 0 Td
(against)Tj
3.0274 0 Td
(CE)Tj
1.4513 0 Td
(and)Tj
1.7348 0 Td
(AE)Tj
1.474 0 Td
(in)Tj
1.0318 0 Td
(clinical)Tj
3.0784 0 Td
(settings)Tj
3.2428 0 Td
(are)Tj
1.4457 0 Td
(mainly)Tj
2.9933 0 Td
(limited)Tj
3.0671 0 Td
(to)Tj
1.0261 0 Td
(benz-)Tj
-35.0359 -1.2983 Td
(imidazoles)Tj
4.4843 0 Td
(\(BMZ\),)Tj
3.1975 0 Td
(and)Tj
1.7348 0 Td
(more)Tj
2.3414 0 Td
(specifically)Tj
4.5694 0 Td
(to)Tj
1.0261 0 Td
(albendazole)Tj
4.9323 0 Td
(and)Tj
1.7291 0 Td
(alternatively)Tj
5.1194 0 Td
(mebendazole)Tj
5.4935 0 Td
(when)Tj
-34.6278 -1.2983 Td
(albendazole)Tj
4.9265 0 Td
(is)Tj
0.8504 0 Td
(not)Tj
1.5761 0 Td
(well)Tj
1.8198 0 Td
(tolerated.)Tj
3.9742 0 Td
(BMZ,)Tj
2.5171 0 Td
(either)Tj
2.5342 0 Td
(alone)Tj
2.3754 0 Td
(or)Tj
1.0998 0 Td
(in)Tj
1.0375 0 Td
(combination)Tj
5.3461 0 Td
(with)Tj
1.9956 0 Td
(other)Tj
2.347 0 Td
(adjuvantive)Tj
-32.3997 -1.3039 Td
(scolicidal)Tj
3.9231 0 Td
(compounds,)Tj
5.1817 0 Td
(are)Tj
1.4513 0 Td
(also)Tj
1.7688 0 Td
(used)Tj
2.058 0 Td
(to)Tj
1.0261 0 Td
(prevent)Tj
3.2541 0 Td
(recurrence)Tj
4.5298 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0261 0 Td
(protoscoleces)Tj
5.5899 0 Td
(spillage)Tj
3.1804 0 Td
(follow-)Tj
-34.6901 -1.2982 Td
(ing)Tj
1.5023 0 Td
(surgery)Tj
3.1918 0 Td
(or)Tj
1.0998 0 Td
(percutaneous)Tj
5.5842 0 Td
(treatment)Tj
4.1329 0 Td
(in)Tj
1.0375 0 Td
(CE)Tj
1.4513 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
-16.8036 -1.2983 Td
(Although)Tj
4.0081 0 Td
(efficacy)Tj
3.2202 0 Td
(of)Tj
1.0148 0 Td
(BMZ)Tj
2.296 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(proved)Tj
3.0218 0 Td
(against)Tj
3.0273 0 Td
(CE)Tj
1.4514 0 Td
(and)Tj
1.7348 0 Td
(AE,)Tj
1.6951 0 Td
(this)Tj
1.6781 0 Td
(relies)Tj
2.313 0 Td
(in)Tj
1.0318 0 Td
(several)Tj
2.9367 0 Td
(vari-)Tj
-34.2876 -1.3039 Td
(ables.)Tj
2.4151 0 Td
(In)Tj
1.1111 0 Td
(CE,)Tj
1.6781 0 Td
(efficacy)Tj
3.2202 0 Td
(of)Tj
1.0148 0 Td
(BMZ)Tj
2.296 0 Td
(varies)Tj
2.5285 0 Td
(depending)Tj
4.4674 0 Td
(on)Tj
1.2756 0 Td
(number,)Tj
3.6453 0 Td
(size,)Tj
1.9105 0 Td
(type,)Tj
2.1373 0 Td
(and)Tj
1.7292 0 Td
(localization)Tj
4.8132 0 Td
(of)Tj
1.0148 0 Td
(cysts)Tj
-35.2571 -1.2983 Td
(that)Tj
1.7744 0 Td
(probably)Tj
3.7644 0 Td
(influence)Tj
3.9175 0 Td
(the)Tj
1.474 0 Td
(penetration)Tj
4.8529 0 Td
(of)Tj
1.0148 0 Td
(drugs,)Tj
2.6985 0 Td
(thus)Tj
1.9389 0 Td
(the)Tj
1.4683 0 Td
(bioavailability)Tj
5.811 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(compound)Tj
-31.1979 -1.2983 Td
(inside)Tj
2.6135 0 Td
(the)Tj
1.4683 0 Td
(cyst,)Tj
1.9843 0 Td
(and)Tj
1.7291 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4683 0 Td
(age)Tj
1.5477 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(patient)Tj
3.0047 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(],)Tj
1.6044 0 Td
(while)Tj
2.3641 0 Td
(the)Tj
1.474 0 Td
(optimal)Tj
3.3052 0 Td
(dosage)Tj
2.9423 0 Td
(and)Tj
1.7292 0 Td
(duration)Tj
3.702 0 Td
(of)Tj
-34.6958 -1.3039 Td
(treatment)Tj
4.1328 0 Td
(have)Tj
2.0636 0 Td
(never)Tj
2.4378 0 Td
(been)Tj
2.126 0 Td
(formally)Tj
3.583 0 Td
(assessed)Tj
3.4752 0 Td
(in)Tj
1.0375 0 Td
(randomized)Tj
5.057 0 Td
(clinical)Tj
3.0784 0 Td
(trials.)Tj
2.4207 0 Td
(For)Tj
1.6271 0 Td
(AE,)Tj
1.7008 0 Td
(long-term)Tj
-32.7399 -1.2982 Td
(BMZ)Tj
2.2903 0 Td
(therapy)Tj
3.2485 0 Td
(improves)Tj
3.9401 0 Td
(the)Tj
1.4684 0 Td
(survival)Tj
3.3392 0 Td
(rate)Tj
1.7461 0 Td
(in)Tj
1.0375 0 Td
(non-radically)Tj
5.5785 0 Td
(operated)Tj
3.7247 0 Td
(patients)Tj
3.3676 0 Td
(and)Tj
1.7291 0 Td
(prevent)Tj
3.2598 0 Td
(recur-)Tj
-34.7298 -1.2983 Td
(rences)Tj
2.7722 0 Td
(after)Tj
2.0353 0 Td
(radical)Tj
2.9196 0 Td
(surgery)Tj
3.1975 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
1.0261 0 Td
(untreated)Tj
4.0762 0 Td
(patients)Tj
3.3676 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.5987 0 Td
(Nevertheless,)Tj
5.4992 0 Td
(several)Tj
2.931 0 Td
(studies)Tj
-33.664 -1.3039 Td
(support)Tj
3.3165 0 Td
(the)Tj
1.474 0 Td
(idea)Tj
1.8708 0 Td
(that)Tj
1.7802 0 Td
(BMZ)Tj
2.2904 0 Td
(exert)Tj
2.1996 0 Td
(a)Tj
0.6577 0 Td
(parasitostatic)Tj
5.4935 0 Td
(rather)Tj
2.6418 0 Td
(than)Tj
2.0296 0 Td
(a)Tj
0.652 0 Td
(parasitocidal)Tj
5.3121 0 Td
(effect,)Tj
2.5908 0 Td
(particularly)Tj
-32.309 -1.2983 Td
(against)Tj
/F11 1 Tf
3.0273 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9922 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
5.6068 0 Td
(lesions,)Tj
3.1578 0 Td
(and)Tj
1.7348 0 Td
(thus)Tj
1.9332 0 Td
(recurrence)Tj
4.5298 0 Td
(rates)Tj
2.1089 0 Td
(are)Tj
1.4457 0 Td
(frequently)Tj
4.3086 0 Td
(reported)Tj
3.6624 0 Td
(after)Tj
2.0352 0 Td
(treat-)Tj
-34.5427 -1.2982 Td
(ment)Tj
2.3073 0 Td
(interruption)Tj
5.1704 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
-6.2815 -1.2983 Td
(Alternative)Tj
4.6714 0 Td
(drugs)Tj
2.4718 0 Td
(and)Tj
1.7348 0 Td
(several)Tj
2.931 0 Td
(natural)Tj
3.0784 0 Td
(compounds)Tj
4.9606 0 Td
(previously)Tj
4.354 0 Td
(known)Tj
3.0047 0 Td
(to)Tj
1.0205 0 Td
(be)Tj
1.1508 0 Td
(effective)Tj
3.515 0 Td
(against)Tj
-34.0892 -1.3039 Td
(different)Tj
3.6566 0 Td
(infectious)Tj
4.1272 0 Td
(and)Tj
1.7348 0 Td
(non-infectious)Tj
6.0831 0 Td
(diseases)Tj
3.3789 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1259 0 Td
(also)Tj
1.7688 0 Td
(tested)Tj
2.5512 0 Td
(in)Tj
/F11 1 Tf
1.0375 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0409 0 Td
(and)Tj
/F11 1 Tf
1.7348 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
-34.3273 -1.2983 Td
(models)Tj
3.101 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
/F11 1 Tf
1.474 0 Td
[()-1()13()18()12()6()4()7()4()7()1()-4()]TJ
/F7 1 Tf
5.3405 0 Td
(species)Tj
2.999 0 Td
(complex,)Tj
3.8494 0 Td
(but)Tj
1.5477 0 Td
(only)Tj
1.9786 0 Td
(few)Tj
1.6158 0 Td
(have)Tj
2.0579 0 Td
(reached)Tj
3.3562 0 Td
(clinical)Tj
3.0727 0 Td
(use)Tj
1.5307 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
1.6044 0 Td
(None)Tj
-34.5427 -1.2983 Td
(of)Tj
1.0147 0 Td
(them)Tj
2.2904 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1203 0 Td
(specifically)Tj
4.5751 0 Td
(designed)Tj
3.7643 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(treatment)Tj
4.1329 0 Td
(of)Tj
1.0148 0 Td
(CE)Tj
1.4514 0 Td
(and)Tj
1.7291 0 Td
(AE)Tj
1.474 0 Td
(\(e.g.)Tj
1.8992 0 Td
(the)Tj
1.474 0 Td
(protein)Tj
3.1521 0 Td
(kinase)Tj
-35.0076 -1.3039 Td
(inhibitors)Tj
4.1385 0 Td
(experimentally)Tj
6.1625 0 Td
(assessed)Tj
3.4696 0 Td
(against)Tj
3.0274 0 Td
(CE)Tj
1.457 0 Td
(or)Tj
1.0941 0 Td
(AE)Tj
1.474 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(previously)Tj
4.3484 0 Td
(used)Tj
2.0636 0 Td
(in)Tj
1.0374 0 Td
(cancer)Tj
2.8403 0 Td
(treat-)Tj
-35.2967 -1.2982 Td
(ment)Tj
2.3073 0 Td
(as)Tj
1.0148 0 Td
(targeted)Tj
3.4639 0 Td
(therapy\),)Tj
3.8098 0 Td
(mainly)Tj
2.9934 0 Td
(because)Tj
3.3165 0 Td
(the)Tj
1.474 0 Td
(development)Tj
5.4084 0 Td
(of)Tj
1.0148 0 Td
(orphan)Tj
3.1238 0 Td
(drugs)Tj
2.4775 0 Td
(for)Tj
1.3833 0 Td
(these)Tj
-31.7875 -1.2983 Td
(neglected)Tj
3.9968 0 Td
(diseases)Tj
3.3789 0 Td
(is)Tj
0.8503 0 Td
(of)Tj
1.0148 0 Td
(very)Tj
1.9219 0 Td
(limited)Tj
3.0728 0 Td
(interest)Tj
3.2087 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(pharmaceutical)Tj
6.3723 0 Td
(industry.)Tj
3.7984 0 Td
(Similarly,)Tj
4.0308 0 Td
(a)Tj
0.652 0 Td
(group)Tj
-34.7922 -1.3039 Td
(of)Tj
1.0147 0 Td
(400)Tj
1.6441 0 Td
(representative)Tj
5.8394 0 Td
(compounds)Tj
4.9549 0 Td
(active)Tj
2.5228 0 Td
(against)Tj
3.0274 0 Td
(malaria,)Tj
3.4526 0 Td
(called)Tj
2.5228 0 Td
(the)Tj
1.4683 0 Td
(ªMalaria)Tj
3.6907 0 Td
(boxº,)Tj
2.3187 0 Td
(have)Tj
2.058 0 Td
(also)Tj
-34.5144 -1.2983 Td
(been)Tj
2.1203 0 Td
(tested)Tj
2.5511 0 Td
(against)Tj
3.0274 0 Td
(a)Tj
0.6576 0 Td
(variety)Tj
2.9254 0 Td
(of)Tj
1.0148 0 Td
(disease)Tj
3.016 0 Td
(pathogens)Tj
4.303 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5987 0 Td
(Preliminary)Tj
4.9833 0 Td
(studies)Tj
2.9877 0 Td
(have)Tj
2.0579 0 Td
(demonstrated)Tj
-31.2432 -1.2983 Td
(tha)Tj
1.4796 0 Td
(some)Tj
2.3301 0 Td
(Malaria)Tj
3.2995 0 Td
(box)Tj
1.7008 0 Td
(compounds)Tj
4.9549 0 Td
(have)Tj
2.0636 0 Td
(consistent)Tj
4.2576 0 Td
(activity)Tj
3.1181 0 Td
(against)Tj
3.0274 0 Td
(helminths)Tj
4.2406 0 Td
(including)Tj
/F11 1 Tf
4.0365 0 Td
[()17(\n)-9()10( )-8()4()]TJ
-34.5087 -1.2982 Td
[(\r)6()11()4()22()-13()]TJ
/F7 1 Tf
(,)Tj
/F11 1 Tf
3.1294 0 Td
[()75(\n)-9()4()13()18()12(\n)-9()-4()]TJ
3.804 0 Td
[()7(\n)-9()4()13()18()12()12(\n)20()]TJ
/F7 1 Tf
(,)Tj
/F11 1 Tf
3.8892 0 Td
[()30()6()-9()3()4()7()9()11()11(\r)6()]TJ
5.2667 0 Td
[()7()-5()3()4()16()18()4()1()12(\r)]TJ
/F7 1 Tf
(,)Tj
4.8359 0 Td
(and)Tj
/F11 1 Tf
1.7291 0 Td
[()-1()13()18()12()6()4()7()4()7()1()-4()]TJ
/F7 1 Tf
5.3461 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(],)Tj
2.3017 0 Td
(and)Tj
1.7291 0 Td
(may)Tj
1.9276 0 Td
(repre-)Tj
-33.9588 -1.3039 Td
(sent)Tj
1.8481 0 Td
(candidate)Tj
4.1046 0 Td
(molecules)Tj
4.2009 0 Td
(to)Tj
1.0261 0 Td
(advance)Tj
/F11 1 Tf
3.4639 0 Td
[()-1()13()18()12()6()4()7()4()7()1()-4()]TJ
/F7 1 Tf
5.3461 0 Td
(drug)Tj
2.109 0 Td
(development)Tj
5.4085 0 Td
(research.)Tj
-26.311 -1.2983 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(following)Tj
3.9798 0 Td
(sections)Tj
3.4129 0 Td
(we)Tj
1.3266 0 Td
(summarize)Tj
4.6544 0 Td
(the)Tj
1.4684 0 Td
(methods)Tj
3.685 0 Td
(used)Tj
2.0636 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
2.5172 0 Td
(drug)Tj
2.1146 0 Td
(efficacy)Tj
3.2202 0 Td
(against)Tj
3.0273 0 Td
(CE)Tj
-36.2718 -1.2983 Td
(and)Tj
1.7291 0 Td
(AE.)Tj
1.7007 0 Td
(We)Tj
1.6101 0 Td
(also)Tj
1.7632 0 Td
(present)Tj
3.1634 0 Td
(an)Tj
1.2019 0 Td
(overview)Tj
3.8097 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(different)Tj
3.6566 0 Td
(compounds)Tj
4.9606 0 Td
(that)Tj
1.7745 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(tested)Tj
2.5512 0 Td
(against)Tj
/F11 1 Tf
-34.5881 -1.3039 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[( )-8(\n)20()16()18()4()4()7()10()-4()]TJ
/F7 1 Tf
4.422 0 Td
(and)Tj
/F11 1 Tf
1.7348 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
5.6069 0 Td
(protoscoleces)Tj
5.5899 0 Td
(and)Tj
1.7291 0 Td
(cysts/vesicles,)Tj
5.6352 0 Td
(including)Tj
4.0422 0 Td
(data)Tj
1.9106 0 Td
(on)Tj
1.2755 0 Td
(their)Tj
-33.9304 -1.2982 Td
(mode)Tj
2.4944 0 Td
(of)Tj
1.0148 0 Td
(action)Tj
2.6986 0 Td
(when)Tj
2.4037 0 Td
(available,)Tj
3.8948 0 Td
(dosage,)Tj
3.1635 0 Td
(and)Tj
1.7291 0 Td
(therapeutic)Tj
4.7338 0 Td
(outcomes.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 256.0251 cm
BT
/F12 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Methods)Tj
3.8693 0 Td
(to)Tj
1.0771 0 Td
(assess)Tj
2.6457 0 Td
(drug)Tj
2.2064 0 Td
(effects)Tj
2.8913 0 Td
(and)Tj
1.7906 0 Td
(efficacy)Tj
3.378 0 Td
(against)Tj
3.2079 0 Td
(CE)Tj
1.4693 0 Td
(and)Tj
1.7953 0 Td
(AE)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 239.0173 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(In)Tj
1.1055 0 Td
(human)Tj
3.0784 0 Td
(infections,)Tj
4.3766 0 Td
(established)Tj
/F11 1 Tf
4.5978 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9978 0 Td
[( )-8(\n)20()16()18()4()4()7()10()-4()]TJ
/F7 1 Tf
4.422 0 Td
(cysts)Tj
2.1203 0 Td
(\(or)Tj
1.4343 0 Td
(metacestodes\))Tj
5.862 0 Td
(can)Tj
1.6271 0 Td
(develop)Tj
3.3165 0 Td
(and)Tj
1.7348 0 Td
(reach)Tj
-34.6731 -1.3039 Td
(the)Tj
1.4683 0 Td
(mature,)Tj
3.3222 0 Td
(fertile)Tj
2.5341 0 Td
(state.)Tj
2.2621 0 Td
(Protoscoleces)Tj
5.6295 0 Td
(are)Tj
1.4514 0 Td
(then)Tj
2.0182 0 Td
(produced)Tj
4.0479 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.4683 0 Td
(germinative)Tj
4.9947 0 Td
(layer)Tj
2.1486 0 Td
(inside)Tj
2.6135 0 Td
(the)Tj
-36.1641 -1.2982 Td
(cyst.)Tj
1.9842 0 Td
(Spillage)Tj
3.2938 0 Td
(of)Tj
1.0148 0 Td
(viable)Tj
2.5512 0 Td
(protoscoleces)Tj
5.5899 0 Td
(after)Tj
2.0352 0 Td
(spontaneous)Tj
5.2554 0 Td
(or)Tj
1.0942 0 Td
(traumatic)Tj
4.0989 0 Td
(cyst)Tj
1.7574 0 Td
(rupture)Tj
3.2542 0 Td
(or)Tj
1.0998 0 Td
(during)Tj
2.9254 0 Td
(sur-)Tj
-35.9544 -1.2983 Td
(gical)Tj
2.0522 0 Td
(intervention)Tj
5.1817 0 Td
(can)Tj
1.6214 0 Td
(give)Tj
1.8312 0 Td
(rise)Tj
1.6441 0 Td
(to)Tj
1.0261 0 Td
(new)Tj
1.8765 0 Td
(cysts)Tj
2.1203 0 Td
(\(recurrence\).)Tj
5.4312 0 Td
(Drugs)Tj
2.6815 0 Td
(against)Tj
3.0274 0 Td
(CE)Tj
1.4514 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(tested)Tj
-34.1289 -1.3039 Td
(both)Tj
2.0579 0 Td
(against)Tj
3.0274 0 Td
(the)Tj
1.4683 0 Td
(metacestode)Tj
5.1647 0 Td
(and)Tj
1.7291 0 Td
(against)Tj
3.0274 0 Td
(the)Tj
1.4683 0 Td
(protoscoleces.)Tj
5.8167 0 Td
(In)Tj
1.1055 0 Td
(AE)Tj
1.474 0 Td
(patients)Tj
3.3675 0 Td
(the)Tj
1.4741 0 Td
(metacestode)Tj
-31.1809 -1.2983 Td
(usually)Tj
3.016 0 Td
(does)Tj
2.0409 0 Td
(not)Tj
1.5704 0 Td
(produce)Tj
3.5206 0 Td
(protoscoleces,)Tj
5.8167 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(majority)Tj
3.6284 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(studies)Tj
2.9877 0 Td
(carried)Tj
3.0387 0 Td
(out)Tj
1.5534 0 Td
(to)Tj
1.0261 0 Td
(assess)Tj
-33.8794 -1.2982 Td
(the)Tj
1.4683 0 Td
(therapeutic)Tj
4.7338 0 Td
(efficacy)Tj
3.2202 0 Td
(of)Tj
1.0147 0 Td
(drugs)Tj
2.4718 0 Td
(against)Tj
3.0274 0 Td
(AE)Tj
1.474 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(done)Tj
2.2281 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(larval)Tj
2.4037 0 Td
(stage)Tj
2.2054 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(parasite.)Tj
-33.4202 -1.2983 Td
(However,)Tj
4.0761 0 Td
(some)Tj
2.3301 0 Td
(authors)Tj
3.2485 0 Td
(have)Tj
2.0579 0 Td
(also)Tj
1.7688 0 Td
(tested)Tj
2.5512 0 Td
(defined)Tj
3.2258 0 Td
(drugs)Tj
2.4775 0 Td
(against)Tj
/F11 1 Tf
3.0274 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
5.6069 0 Td
(protoscoleces)Tj
-31.3623 -1.3039 Td
(isolated)Tj
3.2824 0 Td
(from)Tj
/F11 1 Tf
2.2054 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
1.8198 0 Td
(metacestodes)Tj
5.5219 0 Td
(obtained)Tj
3.736 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(murine)Tj
3.1748 0 Td
(model)Tj
2.7439 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
2.075 0 Td
(For)Tj
1.627 0 Td
(both)Tj
2.0637 0 Td
(CE)Tj
1.4513 0 Td
(and)Tj
1.7291 0 Td
(AE,)Tj
-34.9509 -1.2983 Td
(activity)Tj
3.118 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(compounds)Tj
4.9606 0 Td
(can)Tj
1.627 0 Td
(be)Tj
1.1452 0 Td
(assayed)Tj
/F11 1 Tf
3.2202 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0409 0 Td
(and)Tj
/F11 1 Tf
1.7348 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
(,)Tj
2.0466 0 Td
(although)Tj
3.753 0 Td
(the)Tj
1.4684 0 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(agents)Tj
-34.0608 -1.2983 Td
(reaching)Tj
3.6793 0 Td
(human)Tj
3.0784 0 Td
(clinical)Tj
3.0784 0 Td
(trial)Tj
1.8368 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1203 0 Td
(very)Tj
1.9219 0 Td
(limited.)Tj
3.2995 0 Td
(Lately,)Tj
2.8403 0 Td
(drugs)Tj
2.4718 0 Td
(have)Tj
2.0579 0 Td
(also)Tj
1.7688 0 Td
(been)Tj
2.126 0 Td
(tested)Tj
/F11 1 Tf
2.5511 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
-35.3874 -1.3039 Td
(against)Tj
3.0273 0 Td
(stem)Tj
2.1203 0 Td
(cells)Tj
1.9219 0 Td
(derived)Tj
3.2145 0 Td
(from)Tj
2.2053 0 Td
(the)Tj
1.474 0 Td
(germinative)Tj
4.989 0 Td
(layer)Tj
2.1486 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(metacestode)Tj
5.159 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(],)Tj
3.2542 0 Td
(both)Tj
2.0579 0 Td
(for)Tj
1.389 0 Td
(CE)Tj
-35.4498 -1.2982 Td
(and)Tj
1.7291 0 Td
(AE.)Tj
1.7007 0 Td
(Measurement)Tj
5.743 0 Td
(of)Tj
1.0148 0 Td
(drug)Tj
2.109 0 Td
(activity)Tj
3.1181 0 Td
(against)Tj
3.0273 0 Td
(protoscoleces)Tj
5.5899 0 Td
(is)Tj
0.8504 0 Td
(mainly)Tj
2.9877 0 Td
(directed)Tj
3.4866 0 Td
(towards)Tj
3.4016 0 Td
(the)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 355.9748 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Progress)Tj
4.1598 0 Td
(in)Tj
0.978 0 Td
(the)Tj
1.5874 0 Td
(pharma)Tj
3.3307 0 Td
(cological)Tj
4.0253 0 Td
(treatment)Tj
4.3866 0 Td
(of)Tj
1.0347 0 Td
(human)Tj
3.2315 0 Td
(CE)Tj
1.5874 0 Td
(and)Tj
1.8567 0 Td
(AE)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00064)Tj
3.8197 0 Td
(22)Tj
0 g
2.0905 0 Td
(April)Tj
2.1827 0 Td
(20,)Tj
1.5804 0 Td
(2018)Tj
25.1647 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
endstream
endobj
49 0 obj
<>stream
endstream
endobj
50 0 obj
<>stream
endstream
endobj
51 0 obj
<>stream
endstream
endobj
52 0 obj
<>stream
endstream
endobj
53 0 obj
<>stream
endstream
endobj
54 0 obj
<>stream
BT
66.402 0 Td
(48)Tj
ET
Q
endstream
endobj
55 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 56 0 R/Contents 57 0 R/TrimBox[0 0 612 792]>>
endobj
56 0 obj
[58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R 72 0 R 73 0 R 74 0 R 75 0 R 76 0 R]
endobj
58 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref013)>>
endobj
59 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref014)>>
endobj
60 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref014)>>
endobj
61 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref015)>>
endobj
62 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref010)>>
endobj
63 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref016)>>
endobj
64 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref017)>>
endobj
65 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.g001)>>
endobj
66 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref005)>>
endobj
67 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref018)>>
endobj
68 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref019)>>
endobj
69 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref020)>>
endobj
70 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref005)>>
endobj
71 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref021)>>
endobj
72 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref022)>>
endobj
73 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref023)>>
endobj
74 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref023)>>
endobj
75 0 obj
<>/Border[0 0 0]/Dest(Rpntd.0006422.ref024)>>
endobj
76 0 obj
<>/Border[0 0 0]/A 77 0 R>>
endobj
77 0 obj
<>
endobj
57 0 obj
[78 0 R 79 0 R 80 0 R 81 0 R 82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R 92 0 R 93 0 R]
endobj
78 0 obj
<>stream
q
0.83 0.64 0.02 0 k
437.6126 680.315 m
447.0803 680.315 l
h
f*
346.0535 654.3496 m
355.578 654.3496 l
h
f*
289.2472 628.3276 m
298.7717 628.3276 l
h
f*
270.2551 602.3055 m
279.7795 602.3055 l
h
f*
262.9417 563.3008 m
272.4661 563.3008 l
h
f*
375.9307 550.3181 m
385.3984 550.3181 l
h
f*
519.7039 524.2961 m
529.2283 524.2961 l
h
f*
379.389 407.3386 m
398.948 407.3386 l
h
f*
407.9622 407.3386 m
412.7244 407.3386 l
h
f*
414.9921 407.3386 m
424.5165 407.3386 l
h
f*
456.8315 355.3512 m
466.3559 355.3512 l
h
f*
434.6646 342.3118 m
444.189 342.3118 l
h
f*
422.9291 316.3465 m
427.6346 316.3465 l
h
f*
429.9024 316.3465 m
439.4268 316.3465 l
h
f*
441.6945 316.3465 m
451.2189 316.3465 l
h
f*
531.6661 238.337 m
541.1906 238.337 l
h
f*
393.3921 225.2976 m
402.9165 225.2976 l
h
f*
203.4142 108.3402 m
212.9386 108.3402 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F7 1 Tf
1 TL
-0.004 Tc
0 0 Td
(identification)Tj
5.5842 0 Td
(of)Tj
1.0148 0 Td
(effective)Tj
3.5092 0 Td
(compounds)Tj
4.9606 0 Td
(to)Tj
1.0262 0 Td
(reduce)Tj
2.914 0 Td
(the)Tj
1.474 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
1.0148 0 Td
(CE)Tj
1.457 0 Td
(recurrence)Tj
4.524 0 Td
(after)Tj
2.0353 0 Td
(surgery.)Tj
3.4186 0 Td
(The)Tj
-34.6448 -1.3039 Td
(parasitocidal)Tj
5.3064 0 Td
(effect)Tj
2.3641 0 Td
(of)Tj
1.0147 0 Td
(drugs)Tj
2.4718 0 Td
(against)Tj
3.0331 0 Td
(protoscoleces)Tj
5.5899 0 Td
(can)Tj
1.6214 0 Td
(be)Tj
1.1508 0 Td
(measured)Tj
/F11 1 Tf
4.1103 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(using)Tj
2.3867 0 Td
(simple)Tj
2.8573 0 Td
(proce-)Tj
-34.9679 -1.2982 Td
(dures)Tj
2.4321 0 Td
(involving)Tj
3.9798 0 Td
(vital)Tj
1.9162 0 Td
(staining)Tj
3.4129 0 Td
(with)Tj
1.9956 0 Td
(eosin)Tj
2.3244 0 Td
(or)Tj
1.0998 0 Td
(other)Tj
2.3471 0 Td
(vital)Tj
1.9218 0 Td
(dyes)Tj
1.9899 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.075 0 Td
(Some)Tj
2.4434 0 Td
(authors)Tj
3.2485 0 Td
(combine)Tj
3.7134 0 Td
(this)Tj
-34.8999 -1.2983 Td
(vital)Tj
1.9218 0 Td
(staining)Tj
3.4073 0 Td
(with)Tj
1.9955 0 Td
(the)Tj
1.474 0 Td
(investigation)Tj
5.3575 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(ultra-structural)Tj
6.3099 0 Td
(changes)Tj
3.4016 0 Td
(originated)Tj
4.3313 0 Td
(after)Tj
2.0352 0 Td
(drug)Tj
2.109 0 Td
(expo-)Tj
-34.8262 -1.2983 Td
(sure)Tj
1.9048 0 Td
(as)Tj
1.0148 0 Td
(seen)Tj
1.9729 0 Td
(in)Tj
1.0375 0 Td
(electron)Tj
3.4639 0 Td
(microscopy)Tj
4.8699 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(],)Tj
2.0749 0 Td
(the)Tj
1.4684 0 Td
(measurement)Tj
5.6749 0 Td
(of)Tj
1.0148 0 Td
(indirect)Tj
3.3449 0 Td
(markers)Tj
3.4979 0 Td
(of)Tj
1.0148 0 Td
(parasite)Tj
-32.3544 -1.3039 Td
(damage)Tj
3.3221 0 Td
(including)Tj
4.0422 0 Td
(nucleosomal)Tj
5.2668 0 Td
(fragmentation)Tj
5.9187 0 Td
(and)Tj
1.7347 0 Td
(apoptosis-related)Tj
7.0639 0 Td
(enzyme)Tj
3.2995 0 Td
(activities)Tj
3.7191 0 Td
(in)Tj
-34.367 -1.2982 Td
(treated)Tj
2.9933 0 Td
(protoscoleces)Tj
5.5899 0 Td
([)Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(],)Tj
2.0806 0 Td
(and,)Tj
1.9559 0 Td
(in)Tj
1.0318 0 Td
(few)Tj
1.6158 0 Td
(cases,)Tj
2.4491 0 Td
(the)Tj
1.4683 0 Td
(assessment)Tj
4.6148 0 Td
(of)Tj
1.0148 0 Td
(cyst)Tj
1.7575 0 Td
(formation)Tj
4.2576 0 Td
(capacity)Tj
3.4752 0 Td
(of)Tj
/F11 1 Tf
1.0148 0 Td
[()12()]TJ
-35.3194 -1.2983 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(treated)Tj
2.9933 0 Td
(protoscoleces)Tj
5.5899 0 Td
(after)Tj
2.0353 0 Td
(intraperitoneal)Tj
6.1795 0 Td
(injection)Tj
3.7587 0 Td
(into)Tj
1.8425 0 Td
(rodents,)Tj
3.4809 0 Td
(compared)Tj
4.2406 0 Td
(with)Tj
2.0013 0 Td
(non-)Tj
-34.1686 -1.3039 Td
(treated)Tj
2.9933 0 Td
(parasites)Tj
3.6907 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(].)Tj
2.0749 0 Td
(A)Tj
0.9071 0 Td
(novel)Tj
2.3981 0 Td
(movement-based)Tj
7.1206 0 Td
(assay)Tj
2.262 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.1203 0 Td
(recently)Tj
3.4129 0 Td
(developed)Tj
4.2689 0 Td
(for)Tj
/F11 1 Tf
1.389 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
(-)Tj
-35.1947 -1.2983 Td
(drug)Tj
2.1089 0 Td
(screening)Tj
4.0535 0 Td
(using)Tj
/F11 1 Tf
2.3925 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
5.6069 0 Td
(protoscoleces)Tj
5.5899 0 Td
(cultured)Tj
3.5659 0 Td
(in)Tj
1.0375 0 Td
(microwell)Tj
4.2066 0 Td
(plates.)Tj
2.7269 0 Td
(Morphologi-)Tj
-32.2807 -1.2983 Td
(cal)Tj
1.3209 0 Td
(effects)Tj
2.7269 0 Td
(caused)Tj
2.9197 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.4683 0 Td
(active)Tj
2.5228 0 Td
(compounds)Tj
4.9606 0 Td
(tested)Tj
2.5512 0 Td
(are)Tj
1.4513 0 Td
(then)Tj
2.0183 0 Td
(directly)Tj
3.2315 0 Td
(measured)Tj
4.1045 0 Td
(and)Tj
1.7348 0 Td
(quantified)Tj
4.3086 0 Td
(by)Tj
-36.4986 -1.3039 Td
(image)Tj
2.6305 0 Td
(analysis)Tj
3.3222 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(].)Tj
2.0806 0 Td
(Assays)Tj
2.8743 0 Td
(against)Tj
3.0274 0 Td
(protoscoleces)Tj
5.5899 0 Td
(can)Tj
1.627 0 Td
(also)Tj
1.7689 0 Td
(be)Tj
1.1508 0 Td
(done)Tj
2.2224 0 Td
(after)Tj
2.0352 0 Td
(the)Tj
1.474 0 Td
(intra-cyst)Tj
4.0252 0 Td
(inocula-)Tj
-33.8284 -1.2982 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(drug)Tj
2.109 0 Td
(to)Tj
1.0261 0 Td
(test)Tj
1.6044 0 Td
(its)Tj
1.1452 0 Td
(scolicidal)Tj
3.9231 0 Td
(activity)Tj
3.1181 0 Td
([)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(],)Tj
2.0749 0 Td
(and)Tj
1.7292 0 Td
(by)Tj
1.1848 0 Td
(the)Tj
1.4684 0 Td
(administration)Tj
6.1681 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(drug)Tj
2.1146 0 Td
(to)Tj
-34.4747 -1.2983 Td
(rodent)Tj
2.8969 0 Td
(models)Tj
3.1011 0 Td
(shortly)Tj
2.9877 0 Td
(before)Tj
2.7383 0 Td
(or)Tj
1.0998 0 Td
(after)Tj
2.0353 0 Td
(intraperitoneal)Tj
6.1795 0 Td
(infection)Tj
3.787 0 Td
(with)Tj
2.0013 0 Td
(viable)Tj
2.5511 0 Td
(protoscoleces)Tj
5.5899 0 Td
(to)Tj
-34.9679 -1.3039 Td
(mimic)Tj
2.8176 0 Td
(accidental)Tj
4.2462 0 Td
(spillage)Tj
3.1805 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(peritoneal)Tj
4.2519 0 Td
(cavity)Tj
2.5569 0 Td
(during)Tj
2.9253 0 Td
(a)Tj
0.652 0 Td
(surgical)Tj
3.3165 0 Td
(intervention)Tj
5.176 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
-30.4325 -1.2983 Td
(In)Tj
1.1111 0 Td
(general,)Tj
3.3562 0 Td
(drug)Tj
2.1147 0 Td
(testing)Tj
2.88 0 Td
(against)Tj
3.0273 0 Td
(protoscoleces)Tj
5.5899 0 Td
(in)Tj
1.0375 0 Td
(any)Tj
1.6554 0 Td
(of)Tj
1.0148 0 Td
(those)Tj
2.3414 0 Td
(modalities)Tj
4.371 0 Td
(is)Tj
0.8447 0 Td
(of)Tj
1.0148 0 Td
(advantage)Tj
4.2406 0 Td
(to)Tj
-35.7956 -1.2982 Td
(translate)Tj
3.6339 0 Td
(the)Tj
1.4684 0 Td
(results)Tj
2.8119 0 Td
(mainly)Tj
2.9877 0 Td
(to)Tj
1.0262 0 Td
(avoid)Tj
2.4094 0 Td
(secondary)Tj
4.2746 0 Td
(CE)Tj
1.4513 0 Td
(in)Tj
1.0375 0 Td
(patients.)Tj
3.5887 0 Td
(As)Tj
1.2699 0 Td
(we)Tj
1.3266 0 Td
(mention)Tj
3.6283 0 Td
(hereinafter,)Tj
4.8245 0 Td
(a)Tj
-35.7389 -1.2983 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(drugs)Tj
2.4718 0 Td
(and)Tj
1.7291 0 Td
(compounds)Tj
4.9606 0 Td
(have)Tj
2.058 0 Td
(shown)Tj
2.8516 0 Td
(good)Tj
2.2223 0 Td
(protoscolicidal)Tj
6.1285 0 Td
(activity.)Tj
3.3392 0 Td
(Thus,)Tj
2.4718 0 Td
(drugs)Tj
-32.6662 -1.3039 Td
(against)Tj
3.0273 0 Td
(the)Tj
1.4684 0 Td
(metacestode)Tj
5.159 0 Td
(are)Tj
1.4513 0 Td
(much)Tj
2.5172 0 Td
(more)Tj
2.3414 0 Td
(urgently)Tj
3.5546 0 Td
(needed.)Tj
-18.323 -1.2983 Td
(Drug)Tj
2.3244 0 Td
(activity)Tj
3.118 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1452 0 Td
(measured)Tj
/F11 1 Tf
4.1102 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(against)Tj
3.0274 0 Td
(both)Tj
/F11 1 Tf
2.0579 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9978 0 Td
[( )-8(\n)20()16()18()4()4()7()10()-4()]TJ
/F7 1 Tf
4.4221 0 Td
(s.l.)Tj
1.2755 0 Td
(and)Tj
/F11 1 Tf
1.7348 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
-31.0901 -1.2983 Td
(metacestodes)Tj
5.5218 0 Td
(maintained)Tj
4.7849 0 Td
(in)Tj
1.0374 0 Td
(culture,)Tj
3.2655 0 Td
(although)Tj
/F11 1 Tf
3.7531 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9921 0 Td
[(\r)18()4()14()7()4()4()4()1()4()4()16(\n)-9()-4()]TJ
/F7 1 Tf
5.6069 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(preferred)Tj
3.9345 0 Td
(experimental)Tj
-31.2149 -1.3039 Td
(model)Tj
2.7439 0 Td
(due)Tj
1.6951 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.474 0 Td
(relative)Tj
3.1351 0 Td
(simplicity)Tj
4.1442 0 Td
(in)Tj
1.0318 0 Td
(obtaining)Tj
4.0649 0 Td
(parasite)Tj
3.3279 0 Td
(material)Tj
3.5149 0 Td
(from)Tj
2.2053 0 Td
(experimentally)Tj
-28.3632 -1.2982 Td
(infected)Tj
3.4185 0 Td
(mice)Tj
2.1543 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(feasibility)Tj
4.0365 0 Td
(of)Tj
1.0148 0 Td
(maintaining)Tj
5.1193 0 Td
(and)Tj
1.7292 0 Td
(multiplying)Tj
/F11 1 Tf
4.8755 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(cultured)Tj
3.566 0 Td
(vesicles)Tj
3.1804 0 Td
(of)Tj
-35.3534 -1.2983 Td
(the)Tj
1.4683 0 Td
(parasite)Tj
3.3278 0 Td
(compared)Tj
4.2406 0 Td
(to)Tj
/F11 1 Tf
1.0262 0 Td
[()]TJ
/F7 1 Tf
(.)Tj
/F11 1 Tf
0.9978 0 Td
[( )-8(\n)20()16()18()4()4()7()10()-4()]TJ
/F7 1 Tf
4.422 0 Td
(cysts)Tj
2.1146 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8255 0 Td
(1)Tj
0 g
(\))Tj
1.0318 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.778 0 Td
(However,)Tj
4.0762 0 Td
(the)Tj
/F11 1 Tf
1.474 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0409 0 Td
(vesicular)Tj
-31.8385 -1.3039 Td
(model)Tj
2.7439 0 Td
(has)Tj
1.542 0 Td
(some)Tj
2.3301 0 Td
(limitations)Tj
4.5354 0 Td
(regarding)Tj
4.0932 0 Td
(the)Tj
1.4683 0 Td
(extrapolation)Tj
5.5389 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
/F11 1 Tf
1.4683 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(effects)Tj
2.7269 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
/F11 1 Tf
1.4683 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
1.8198 0 Td
(sce-)Tj
-35.8523 -1.2983 Td
(nario.)Tj
2.5738 0 Td
(First,)Tj
2.2677 0 Td
(assessment)Tj
4.6148 0 Td
(of)Tj
1.0148 0 Td
(total)Tj
2.0012 0 Td
(loss)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(parasite)Tj
3.3279 0 Td
(viability)Tj
3.4129 0 Td
(after)Tj
2.0352 0 Td
(treatment)Tj
4.1386 0 Td
(\(parasitocidal)Tj
5.6466 0 Td
(effect\))Tj
2.7042 0 Td
(is)Tj
-36.4476 -1.2983 Td
(difficult.)Tj
3.5773 0 Td
(This)Tj
1.9899 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.1203 0 Td
(most)Tj
2.2053 0 Td
(frequently)Tj
4.3087 0 Td
(approached)Tj
4.9039 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(study)Tj
2.3867 0 Td
(of)Tj
1.0148 0 Td
(macroscopic)Tj
5.2781 0 Td
(alterations)Tj
-31.9802 -1.2982 Td
(\(e.g.,)Tj
2.1259 0 Td
(shrinking)Tj
4.0705 0 Td
(of)Tj
1.0148 0 Td
(cysts)Tj
2.1203 0 Td
(or)Tj
1.0942 0 Td
(detachment)Tj
4.9493 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(germinative)Tj
4.9946 0 Td
(layer\))Tj
2.4888 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(],)Tj
2.075 0 Td
(microscopical)Tj
5.7883 0 Td
(changes)Tj
3.4015 0 Td
(in)Tj
-36.6063 -1.3039 Td
(the)Tj
1.4683 0 Td
(germinative)Tj
4.9946 0 Td
(layer)Tj
2.1486 0 Td
(\(destruction)Tj
5.1137 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(cells)Tj
1.9218 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(layer\))Tj
2.4888 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(],)Tj
2.075 0 Td
(or)Tj
1.0998 0 Td
(leaking)Tj
3.1011 0 Td
(of)Tj
1.0148 0 Td
(parasite-derived)Tj
-30.4155 -1.2983 Td
(compounds)Tj
4.9605 0 Td
(to)Tj
1.0205 0 Td
(the)Tj
1.474 0 Td
(culture)Tj
3.0387 0 Td
(medium)Tj
3.6057 0 Td
(and)Tj
1.7291 0 Td
(subsequent)Tj
4.7055 0 Td
(assessment)Tj
4.6091 0 Td
(of)Tj
1.0148 0 Td
(their)Tj
2.109 0 Td
(associated)Tj
4.2576 0 Td
(enzyme)Tj
3.2995 0 Td
(\(e.g.)Tj
-35.824 -1.2983 Td
(alkaline)Tj
3.3165 0 Td
(phosphatase,)Tj
5.3517 0 Td
(phosphoglucoisomerase\))Tj
10.165 0 Td
(activity)Tj
3.1181 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(21)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(22)Tj
0 g
(].)Tj
3.9515 0 Td
(Although)Tj
4.0025 0 Td
(these)Tj
2.2563 0 Td
(assays)Tj
2.6249 0 Td
(corre-)Tj
-34.7865 -1.3039 Td
(late)Tj
1.6214 0 Td
(well)Tj
1.8198 0 Td
(with)Tj
1.9956 0 Td
(parasite)Tj
3.3278 0 Td
(damage,)Tj
3.549 0 Td
(parasitocidal)Tj
5.3064 0 Td
(activity)Tj
3.1181 0 Td
(could)Tj
2.4548 0 Td
(only)Tj
1.9785 0 Td
(be)Tj
1.1452 0 Td
(totally)Tj
2.7099 0 Td
(proven)Tj
3.0388 0 Td
(after)Tj
2.0352 0 Td
(inocula-)Tj
-34.1005 -1.2982 Td
(tion)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(treated)Tj
2.9934 0 Td
(parasitic)Tj
3.5943 0 Td
(material)Tj
3.5149 0 Td
(into)Tj
1.8425 0 Td
(a)Tj
0.652 0 Td
(rodent)Tj
2.897 0 Td
(model,)Tj
2.9707 0 Td
(or,)Tj
1.3209 0 Td
(alternatively,)Tj
5.3461 0 Td
(re-culturing)Tj
5.04 0 Td
(the)Tj
-34.4974 -1.2983 Td
(material)Tj
/F11 1 Tf
3.5149 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0409 0 Td
(in)Tj
1.0375 0 Td
(order)Tj
2.4208 0 Td
(to)Tj
1.0261 0 Td
(prove)Tj
2.4945 0 Td
(the)Tj
1.4683 0 Td
(lack)Tj
1.8198 0 Td
(of)Tj
1.0148 0 Td
(parasite)Tj
3.3279 0 Td
(growth.)Tj
3.2995 0 Td
(Second,)Tj
3.3505 0 Td
(the)Tj
1.4684 0 Td
(development)Tj
5.4084 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
-35.7219 -1.3039 Td
(cysts)Tj
2.1146 0 Td
(in)Tj
1.0375 0 Td
(primary)Tj
3.4582 0 Td
(infections)Tj
4.1499 0 Td
(in)Tj
1.0375 0 Td
(natural)Tj
3.0784 0 Td
(hosts)Tj
2.2733 0 Td
(\(after)Tj
2.3755 0 Td
(oral)Tj
1.7801 0 Td
(infection)Tj
3.7927 0 Td
(with)Tj
1.9956 0 Td
(parasite)Tj
3.3279 0 Td
(eggs\))Tj
2.2733 0 Td
(differs)Tj
2.7496 0 Td
(from)Tj
-35.4441 -1.2983 Td
(the)Tj
1.4683 0 Td
(development)Tj
5.4085 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(cysts)Tj
/F11 1 Tf
2.1146 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
(,)Tj
2.2734 0 Td
(both)Tj
2.0579 0 Td
(for)Tj
1.389 0 Td
(CE)Tj
1.4513 0 Td
(and)Tj
1.7291 0 Td
(AE.)Tj
1.7008 0 Td
(For)Tj
1.6271 0 Td
(CE,)Tj
1.6781 0 Td
(cyst)Tj
1.7574 0 Td
(growth)Tj
3.0728 0 Td
(usually)Tj
3.016 0 Td
(leads)Tj
2.211 0 Td
(to)Tj
-36.4589 -1.2983 Td
(the)Tj
1.4683 0 Td
(formation)Tj
4.2633 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(external)Tj
3.4299 0 Td
(laminated)Tj
4.2179 0 Td
(and)Tj
1.7292 0 Td
(adventitial)Tj
4.422 0 Td
(layers)Tj
2.5114 0 Td
(of)Tj
1.0148 0 Td
(variable)Tj
3.3562 0 Td
(thickness)Tj
3.9288 0 Td
([)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(].)Tj
2.075 0 Td
(In)Tj
1.1112 0 Td
(AE)Tj
-36.0111 -1.3039 Td
(patients,)Tj
3.5943 0 Td
(cysts)Tj
2.1146 0 Td
(grow)Tj
2.2507 0 Td
(forming)Tj
3.4866 0 Td
(a)Tj
0.6519 0 Td
(stromatous)Tj
4.7055 0 Td
(mass)Tj
2.194 0 Td
([)Tj
0.83 0.64 0.02 0 k
(23)Tj
0 g
(].)Tj
2.0806 0 Td
(In)Tj
1.1055 0 Td
(both)Tj
2.0637 0 Td
(cases,)Tj
2.4434 0 Td
(access)Tj
2.6475 0 Td
(of)Tj
1.0148 0 Td
(drugs)Tj
2.4718 0 Td
(to)Tj
1.0262 0 Td
(the)Tj
1.4683 0 Td
(living)Tj
-35.3194 -1.2982 Td
(parasite)Tj
3.3278 0 Td
(cells)Tj
1.9162 0 Td
(is)Tj
0.8504 0 Td
(more)Tj
2.3414 0 Td
(limited)Tj
3.0671 0 Td
(than)Tj
2.0296 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
/F11 1 Tf
1.4684 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(conditions.)Tj
4.6998 0 Td
(In)Tj
1.1112 0 Td
(addition,)Tj
3.821 0 Td
(because)Tj
3.3222 0 Td
(cells)Tj
1.9162 0 Td
(growing)Tj
/F11 1 Tf
-33.9701 -1.2983 Td
[()12()]TJ
1.0147 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(are)Tj
1.4457 0 Td
(not)Tj
1.5761 0 Td
(the)Tj
1.4683 0 Td
(exact)Tj
2.262 0 Td
(dissociated)Tj
4.6205 0 Td
(replicates)Tj
3.9855 0 Td
(of)Tj
1.0148 0 Td
(their)Tj
/F11 1 Tf
2.1089 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
1.8198 0 Td
(counterparts,)Tj
/F11 1 Tf
5.5276 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(models)Tj
3.1011 0 Td
(do)Tj
-36.0678 -1.2983 Td
(not)Tj
1.5703 0 Td
(take)Tj
1.8766 0 Td
(into)Tj
1.8368 0 Td
(consideration)Tj
5.7089 0 Td
(the)Tj
1.4684 0 Td
(potentially)Tj
4.4617 0 Td
(synergistic)Tj
4.4617 0 Td
(antiparasitic)Tj
5.142 0 Td
(effect)Tj
2.3641 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(host's)Tj
2.4888 0 Td
(immune)Tj
-33.8624 -1.3039 Td
(system,)Tj
3.1634 0 Td
(which)Tj
2.6475 0 Td
(may,)Tj
2.1544 0 Td
(at)Tj
0.9524 0 Td
(least)Tj
1.9842 0 Td
(partially,)Tj
3.7134 0 Td
(explain)Tj
3.1238 0 Td
(some)Tj
2.33 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(outcomes)Tj
4.0876 0 Td
(observed)Tj
3.7984 0 Td
(in)Tj
/F11 1 Tf
1.0318 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
1.8198 0 Td
(models.)Tj
-34.3046 -1.2983 Td
(Nevertheless,)Tj
5.4935 0 Td
(the)Tj
/F11 1 Tf
1.4683 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(vesicular)Tj
3.7304 0 Td
(model)Tj
2.7439 0 Td
(has)Tj
1.542 0 Td
(shown)Tj
2.8517 0 Td
(to)Tj
1.0204 0 Td
(be)Tj
1.1509 0 Td
(very)Tj
1.9275 0 Td
(valuable)Tj
3.4923 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(high-through-)Tj
-31.3396 -1.2982 Td
(put)Tj
1.5647 0 Td
(screening)Tj
4.0478 0 Td
(of)Tj
1.0148 0 Td
(compounds,)Tj
5.1874 0 Td
(specially)Tj
3.5943 0 Td
(applying)Tj
3.668 0 Td
(defined)Tj
3.2258 0 Td
(assays)Tj
2.6249 0 Td
(that)Tj
1.7801 0 Td
(show)Tj
2.3017 0 Td
(to)Tj
1.0205 0 Td
(correlate)Tj
3.719 0 Td
(well)Tj
1.8199 0 Td
(with)Tj
-35.5689 -1.3039 Td
(the)Tj
1.4683 0 Td
(loss)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(parasite)Tj
3.3278 0 Td
(activity,)Tj
3.3392 0 Td
(e.g.)Tj
1.5648 0 Td
(the)Tj
1.4683 0 Td
(measurement)Tj
5.6692 0 Td
(of)Tj
1.0148 0 Td
(phosphoglucoisomerase)Tj
9.8249 0 Td
(\(PGI\))Tj
2.5114 0 Td
(activity)Tj
3.1181 0 Td
(in)Tj
-36.0167 -1.2983 Td
(the)Tj
1.4626 0 Td
(culture)Tj
3.0331 0 Td
(medium)Tj
3.5943 0 Td
(after)Tj
2.0296 0 Td
(drug)Tj
2.1089 0 Td
(exposure,)Tj
4.0309 0 Td
(avoiding)Tj
3.685 0 Td
(the)Tj
1.4627 0 Td
(unnecessary)Tj
5.091 0 Td
(use)Tj
1.525 0 Td
(of)Tj
1.0091 0 Td
(experimental)Tj
5.4538 0 Td
(animals)Tj
-34.486 -1.2983 Td
([)Tj
0.83 0.64 0.02 0 k
(24)Tj
0 g
(].)Tj
2.0749 0 Td
(Nevertheless,)Tj
5.4992 0 Td
(concentration)Tj
5.8166 0 Td
(range)Tj
2.4605 0 Td
(of)Tj
1.0148 0 Td
(drugs)Tj
2.4775 0 Td
(tested)Tj
/F11 1 Tf
2.5511 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
/F7 1 Tf
2.0466 0 Td
(should)Tj
2.914 0 Td
(consider)Tj
3.651 0 Td
(that)Tj
1.7802 0 Td
(bioavil-)Tj
-33.3012 -1.3039 Td
(ability)Tj
/F11 1 Tf
2.6928 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()15()3()]TJ
/F7 1 Tf
(,)Tj
2.0466 0 Td
(both)Tj
2.058 0 Td
(in)Tj
1.0375 0 Td
(plasma)Tj
3.033 0 Td
(and)Tj
1.7291 0 Td
(intra-cyst,)Tj
4.252 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1508 0 Td
(three)Tj
2.262 0 Td
(to)Tj
1.0262 0 Td
(ten-fold)Tj
3.4129 0 Td
(lower)Tj
2.4491 0 Td
(than)Tj
2.0296 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
/F11 1 Tf
1.4683 0 Td
[()12()]TJ
1.0148 0 Td
[()-13()14()7(\n)20()]TJ
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 183.2882 23.6976 re
W* n
q
183.2315 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 355.9748 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Progress)Tj
4.1598 0 Td
(in)Tj
0.978 0 Td
(the)Tj
1.5874 0 Td
(pharma)Tj
3.3307 0 Td
(cological)Tj
4.0253 0 Td
(treatment)Tj
4.3866 0 Td
(of)Tj
1.0347 0 Td
(human)Tj
3.2315 0 Td
(CE)Tj
1.5874 0 Td
(and)Tj
1.8567 0 Td
(AE)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
163.5591 34.9228 m
317.7071 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(Neglected)Tj
4.6417 0 Td
(Tropical)Tj
3.7135 0 Td
(Disease)Tj
3.5433 0 Td
(s)Tj
0.7158 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8197 0 Td
(1/journal.pn)Tj
5.1237 0 Td
(td.00064)Tj
3.8197 0 Td
(22)Tj
0 g
2.0905 0 Td
(April)Tj
2.1827 0 Td
(20,)Tj
1.5804 0 Td
(2018)Tj
25.1647 0 Td
(4)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
79 0 obj
<>stream
endstream
endobj
80 0 obj
<>stream
endstream
endobj
81 0 obj
<>stream
endstream
endobj
82 0 obj
<>stream
endstream
endobj
83 0 obj
<>stream
endstream
endobj
84 0 obj
<>stream
endstream
endobj
85 0 obj
<>stream
endstream
endobj
86 0 obj
<>stream
endstream
endobj
87 0 obj
<>stream
endstream
endobj
88 0 obj
<>stream
endstream
endobj
89 0 obj
<>stream
endstream
endobj
90 0 obj
<>stream
endstream
endobj
91 0 obj
<>stream
endstream
endobj
92 0 obj
<>stream
endstream
endobj
93 0 obj
<>stream
BT
66.402 0 Td
(48)Tj
ET
Q
endstream
endobj
94 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 97 0 R/Contents 98 0 R/TrimBox[0 0 612 792]>>
endobj
96 0 obj
<>stream
xÜÝx[ç™&ìýw³I&É$“ÄI\bÇEV£ºdÉê’Ø@ôÞÊ)h½‚À’ Ø vŠ]ͪî5Žã÷&ËEn²eË’lY•û†(ËVÊ?;Ù\Ï…ëÃ@)¶lóæó~ß9ú£™¼ÿâA:¼tè×ïÍÍǯޟ›c¯=ðÉë~úÆCW®_í%xóñ7¾2Ÿ~òù[~oNyŒÎo?>%'ßybJ¦¼!÷é”wÂÓSïþqJN¿÷ä”|yôO—ç©/ߣrúÝ?Ñ¡ŸÂãWGÿLçÌûOOIö¥+Ùw~ýÁ3tÎ|ðÌW<ýÝ9óá3_ôì?*g?~ŽNöf¯œ;ö:ç?yþoÍç?yáü§/^8þÒ…ã/ÿ§åâg¯LÉ¥Ï_½ZèwÒ¿·ì§²o?ñÚÿ•\:ñúÅÏ߸0‘7/|~¹xâðµäÒÉ#ãç>?ÿÑÉ^zöÑîÚ@È('å¥zq!)g¸P~È$/#å>È¡áÚTl‡šãÂn\èÆ„TèÃÅ~Bì#`-pkùXx©—.
Ï©æÂ"jUwÕøÝÙõþ\8þæø—ïŸz{ü‹7Ç¿x=“×Æ?§rñóW/žxõâ×.|ýÒÉ7.~ñÆ…¯OÖ'!oÒ9êðùSoÑ9wúÉ9wúȹS·/Ð9ýö…‰¹pú²ÀgÏ<üÉ~åkX9
¾löWyçÂéïϹ“GÎ~ñXŸ?õ6ú³ôúâ—ï^úê=¸rì½gÜß“ªrz-ˆ]'wèU.£Ömº¦8
j¡„xH4h×l:ø¸I#!µR»‹^3F¿'d7ô4×>ÿä}gN¼3>þùø¥ãÏ~pöô‘/O¼~úó×¾üⵯO¿yþ«#ϼséÌ»¿zþúŸ=ñú™ã¯ùôÕ¯>yå«c/}ìÕŸÂßÐ#ã_½7~îÃñ‹_út|ü3ê«QùlüÜGã'Þþú½?yå‰wÿ¼ÿð£Û_»¯áù=¡'zõ“â‘rF°d,Ê {vÐóò®òçFB÷5›zü‚*t£Wx·ƒ³ÔºK_²XWr—M¸.„–FÂNèPqMr–IÁ¶¡·Qí1£N3j3At~§%Væª*sD¼ú
»¦Ê5•›û¾ÑÖŠ]•;ڣázïP»»%|_Ý;[ŸÞ×õÜÁž¿ê{fß¡žTÂC¸VßÛQ÷ÐpÇHSUµKç×É«ÝÆæøþΡÖT}™·Ìn
ÚMQŸ».ZÞX[Õœ¬mkLtµ5õwµ÷wïêß=:¸gl8“¡]#;‡·
öôÒunàâÈöžÁÞNø8|‘Ö†úTmUmU¤:R+óTøía¹ÜmŠùLµ!kCÔÝt&Ë{›bÛ[«ÚâƒíuCéúátb¤#5ÖÕ¸£»y¬«i´³q¤£a8éhëjÞÙÓº«—
,ƺZF:š‡Ó¦¡tãpºq´>Ò:ÚÙ2ÔÖ°½©2ØšI7Žu6ïènÝÕ×Ngg_ÛhoËpwó`Wã`'•ÞÖúödeª&xb!G™—tY1R¯Ä5"•‚-“0$¢±°¥b†\ÊTÊÙ*O%ç#2***ˆZ.Ì
\A¤|:ô«…èjÑ*ÅT)Á)¦¢‚«¥ÖpQ&Ƥ\!#TJV£Cq×k£7Kp+³1´Ö-JóZ±aXÈÆ籉ùÃ<9—Mæ±L³J³J³Šõ³Š¨äæ3È»ØÖU|÷Fih›ª‚E¹º¨Ð*$Æ
±©BdŠ
MU\c5CW™¯-_)ó-äÙf2wwꦗç°ÍK„ŽuH°ˆ²MÕ«˜)JÔjÔh0ÙÍi6:\QÈB™‚§T µ¨” ”BeÀÕz¢1⸙0ZÒˆP¦(ø¥f«8¿dóÚ-˯˜;#ïö›o¹éw¿½ùw×M»å†…³þ°~éÅëgó·Í—2– ìåZþjT°5œÕö-g-Ê]‡ó6ê[A!,0JK¼„$æÀ#6ÌMÈJ>&å@p9@„JL¨$¸J‚ªÄZ"ú&J¡V!ÐÈøj_)åˤ|‰˜/A"±H$‘ˆ¤2±L!Q(¥JD†¨j5¢E”i0–T¹®„“·jó
óWü"où/n¾qpZ±a¶ÐŸ§ŒÍT×Þ©INÚo#ZoÖ·þÞ”¾ÕÑ;Í7|›{à7†¶É«ÿ'ø/œàOÕ7[ïtõÍò
Íò
憖ª9°¹áÁmä7Þ¿2ºk®£ë6,u½¢ò·ÒÈ
²è-ʪÛU5wjjghëg¡É<¬až®i¡iž.1]½Yä¹g¹žc¼¥¿‘e¸™c¼gºSHΙó„dß8›MÌfhg©òŠ”sŠs3™_¬˜_$ŸW$S(É£S$]$›U$ŸU¬˜ÅPÎ.EòXê9lÍ\®vO™ÏQÍc+ç°d³K¥³,æ²ùêÅBí]bl©ÏÍr¹~¥ÒY¡0,“ðýž»e:ú¥Õ*rÚ¼VcY§±¬ÕZÖhÍ«Õæ•ÈDV«tÖhlk´öµZû:Ô1%S˜ ؼFiNA%ýtÊÅ\Š^iLúÊÿuiN1&ýt
3áéTfý‡I3kLXd™ ‹ï•&0óŸLšŸþsH3kLz‘•&µøOÇ&üŠ”4)mýÕؼxâÍk“æ[ãg? œúèåçÞÙŸ
—›U%K/.ºBš<›ŠÞta|7.p-)TŠ ›^€§–´„äJ WÊIeºÒ}ÿPë[OÝ{惗ƿxkü$äÍñ“oPÒ„¿ªð×ö³W.@>å…Ío¤ù
63Ò¼˜‘æù“ÀÌï–æ‘ @ÀæÕ™9¡Ô+°y
ºœnæ¹Òü~cNXòÚ¤9þÕQðæ'GŸ{ð@/%M³ê"M`¦•9™YiB;ªŸ~äÀ©c‡Ç/$^úúèÙS‡Oöê©ã¯Àã™/Þ Î_üòK_½Kcó— dêÿ>‹§Þ¡~†pæ}êÓÙ3ùàâÙ÷ÏŸ9zþô»gOùêØ+'Ž<óÁó¿þøÞçõÿywÃGÊíµ>Ц>å#î¾:å#íÆ?õ9ïvîOézƒ¢:ýÖ d•“»Ì̼KW¼ˆ(¾ËÊ_Ô”Dô‚ .°+ÙFi©QƲjÄ.ƒÚM¢Rk5j¬&Ìë0E‚ŽÊ-âÑU84Õn´©œìóŽ´TìÌHs¤©l áLøvRÒ¬½\š½»ëë]¸SÉŒ;Ð]Õ÷¶4U×zL!#Rí!ûköö§‡Z“Ér…èg û›j«ÒMIêøöæ¾®öÁ¾. $ÐrÏèð=c#÷ì¹glx÷(`sp`s¨
xîš°çHÏP_Wwº;Ýhi¨o¨¯©«ŽUGËcåÁH¤éˆúmUA[mØ‘Šº[jü‰pOc´¿¥j f°½–’f{ýPFš L`fVš`Ï‘ÎæŽî–É4vfŒÙÞ4ÔÞ¡¥¹£«P9ÖÙ2šn‚€1áS™´Àãhgˆu0êoKô¶Ôu5Å;k:ª[ê"‰X ²ÌYî³]F·3B+V+¸J)K&iN0S&a*d,DÉQ+ùjŸÆfVš¹ÞÌ0ó2ijBš™j¹hj2À&Ø”PÒÌF)Ååb
›
)®Tj5®Å0,#MbRšK¾œ\#Ô/åâXØ„4¹ä\Žy`“IÎf˜f3Œy Äã<†iÓ²Œk_#òl–—¨#¥x”§‹e¤™&U\S5Cÿ4g1Ó(iÓKylóbc2ð4ÍÕBc”O„YjoFš–ï’¦¶bR¾Iê_‘æÌuüÛ3Ò\¸U$ÁLþh}kOçöÑ®þÁÖötFš‰o‘f›—I3žj§hi¶NH³¦;ßÞÒLvÔVÇ\v»VíÀ´´4£‘JÛˆ ÀL9›Eª51fe<©ªô—ÑÒô‘/Äÿ*sg¤éÚ þ âóe¤iÑIޢ׃4$H“ôÙ,ÀLŸÍœ•¦C;
¸Û¤óMHÓ\á0—;H¨“–fÌIVºÌØô˜˜“Ø´ÖRÒt4—¹Z+